Cargando…

The antidepressant effect and safety of non-intranasal esketamine: A systematic review

BACKGROUND: The introduction of esketamine into the field of psychiatry comes on the heels of excitement from studies on racemic ketamine. While the intranasal route has been the most studied to date, other modes of administration of esketamine may also be of interest in the management of depression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith-Apeldoorn, Sanne Y, Vischjager, Maurice, Veraart, Jolien KE, Kamphuis, Jeanine, aan het Rot, Marije, Schoevers, Robert A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112628/ https://www.ncbi.nlm.nih.gov/pubmed/35546042 http://dx.doi.org/10.1177/02698811221084055

Ejemplares similares

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2021)

Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2019)

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
por: Smith-Apeldoorn, Sanne Y., et al.
Publicado: (2020)

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
por: Breeksema, Joost J., et al.
Publicado: (2023)

The Effects of Tryptophan on Everyday Interpersonal Encounters and Social Cognitions in Individuals with a Family History of Depression
por: Hogenelst, Koen, et al.
Publicado: (2015)

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study
por: Breeksema, Joost J., et al.
Publicado: (2022)

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities
por: Veraart, Jolien K E, et al.
Publicado: (2021)

The Influence of Affective Empathy and Autism Spectrum Traits on Empathic Accuracy
por: aan het Rot, Marije, et al.
Publicado: (2014)

Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review
por: Potijk, Marieke R., et al.
Publicado: (2020)

Empathic accuracy and oxytocin after tryptophan depletion in adults at risk for depression
por: Hogenelst, Koen, et al.
Publicado: (2015)

Increased alcohol use to cope with COVID-19-related anxiety one year into the coronavirus pandemic
por: aan het Rot, Marije, et al.
Publicado: (2023)

Childhood Trauma and Adult Somatic Symptoms
por: Eilers, Hanna, et al.
Publicado: (2023)

Intrapersonal and Interpersonal Concomitants of Facial Blushing during Everyday Social Encounters
por: aan het Rot, Marije, et al.
Publicado: (2015)

Intranasal esketamine and the dawn of precision psychiatry
por: Watts, Devon, et al.
Publicado: (2021)

Is (S)-norketamine an alternative antidepressant for esketamine?
por: Hashimoto, Kenji, et al.
Publicado: (2018)

Characteristics of patients expressing an interest in ketamine treatment: results of an online survey
por: Veraart, Jolien K. E., et al.
Publicado: (2018)

Homesickness in social context: An ecological momentary assessment study among 1st‐year university students
por: Nauta, Maaike H., et al.
Publicado: (2019)

The role of intranasal esketamine in treatment-resistant depression
por: Fraga, A., et al.
Publicado: (2021)

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021)

Victims of Bullying: Emotion Recognition and Understanding
por: Franzen, Minita, et al.
Publicado: (2021)

Youth Psychopathology in Daily Life: Systematically Reviewed Characteristics and Potentials of Ecological Momentary Assessment Applications
por: Thunnissen, Marjolein R., et al.
Publicado: (2021)

Intra‐ and Interindividual Variability in the Behavioral, Affective, and Perceptual Effects of Alcohol Consumption in a Social Context
por: Franzen, Minita, et al.
Publicado: (2018)

Formal representation of ambulatory assessment protocols in HTML5 for human readability and computer execution
por: Batalas, Nikolaos, et al.
Publicado: (2018)

Interpersonal responses to facial expressions of disgust, anger, and happiness in individuals with varying levels of social anxiety
por: aan het Rot, Marije, et al.
Publicado: (2022)

Rumination, worry and negative and positive affect in prolonged grief: A daily diary study
por: Eisma, Maarten C., et al.
Publicado: (2021)

Intranasal Esketamine administration in catatonia: a case report.
por: Romay, J., et al.
Publicado: (2023)

Dissociating the Clinical Role and Economic Value of Intranasal Esketamine
por: Dadiomov, David
Publicado: (2020)

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder
por: Veraart, J.K.E., et al.
Publicado: (2023)

Intranasal esketamine use in bipolar disorder: A case report
por: Skriptshak, Courtney, et al.
Publicado: (2021)

The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
por: Pepe, Maria, et al.
Publicado: (2023)

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
por: Liu, Peng, et al.
Publicado: (2022)

A moderate dose of alcohol selectively reduces empathic accuracy
por: Thiel, Freya, et al.
Publicado: (2018)

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study
por: Takahashi, Nagahide, et al.
Publicado: (2021)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
por: Carter, Maximilian, et al.
Publicado: (2022)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
por: Hernandez Huerta, D., et al.
Publicado: (2022)

Median effective dose of esketamine for intranasal premedication in children with congenital heart disease
por: Huang, Jiajia, et al.
Publicado: (2023)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021)

A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial
por: Lu, Xinlei, et al.
Publicado: (2022)

Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression
por: Skala, Katrin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6truvo2hnlag3a1i4je2c2bru0